Noramco, an API supplier specialised in controlled substances, has launched Noramco Group, which it describes as a “comprehensive North American-based supply chain solution” for clinical and commercial APIs and drug products. Noramco Group unites the capabilities of three subsidiaries:

* Delaware-based Noramco itself, which supplies APIs for both branded and generic drugs that are used in over 350 products

* Purisys, a Georgia-based supplier of CDMO services and pharmaceutical reference standards, with specialised capabilities in controlled substance APIs